Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a technology-enabled decentralized clinical trial platform that completed its business combination with LifeSci Acquisition Corp, a blank-check company sponsored by LifeSci Capital, in October 2021. The SPAC vehicle had priced its initial public offering in 2020, targeting the healthcare and life sciences sector. Science 37 operates a network-as-a-service model designed to bring clinical trial participation directly to patients in their homes, positioning the company at the intersection of healthcare technology and clinical research outsourcing. The 10-Q filing dated November 15, 2021 represents the company's first quarterly report as a publicly traded combined entity under the SNCE ticker. Sign up at SpacDesk for full filing history, deal metrics, and sponsor-level data on SNCE and hundreds of other SPAC transactions.